SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001723128-18-000019
Filing Date
2018-05-21
Accepted
2018-05-21 08:09:04
Documents
21
Period of Report
2018-05-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amrx-8kx5x21x2018.htm 8-K 26327
2 EXHIBIT 99.1 exhibit991.htm EX-99.1 42611
3 exhibit991001.jpg GRAPHIC 90407
4 exhibit991002.jpg GRAPHIC 227721
5 exhibit991003.jpg GRAPHIC 109469
6 exhibit991004.jpg GRAPHIC 99695
7 exhibit991005.jpg GRAPHIC 114102
8 exhibit991006.jpg GRAPHIC 116873
9 exhibit991007.jpg GRAPHIC 98046
10 exhibit991008.jpg GRAPHIC 97244
11 exhibit991009.jpg GRAPHIC 125988
12 exhibit991010.jpg GRAPHIC 101457
13 exhibit991011.jpg GRAPHIC 95402
14 exhibit991012.jpg GRAPHIC 74650
15 exhibit991013.jpg GRAPHIC 97570
16 exhibit991014.jpg GRAPHIC 112520
17 exhibit991015.jpg GRAPHIC 87913
18 exhibit991016.jpg GRAPHIC 81363
19 exhibit991017.jpg GRAPHIC 96767
20 exhibit991018.jpg GRAPHIC 44730
21 exhibit991019.jpg GRAPHIC 164238
  Complete submission text file 0001723128-18-000019.txt   2875968
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38485 | Film No.: 18848423
SIC: 2834 Pharmaceutical Preparations